Effects of d-cycloserine on the behavior and ERK activity in the amygdala: Role of individual anxiety levels

Behavioural Brain Research

Volumn 187, Issue 2, 2008, Pages 246-253

  Wu, Shey Lin ^a,b,c   Hsu, Li Sung ^d   Tu, Wei Ting ^e   Wang, Wen Fu ^a   Huang, Yao Ting ^a   Pawlak, Cornelius Rainer ^f   Ho, Ying Jui ^d  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b DA YEH UNIVERSITY   (Taiwan)

^c CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^e NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^f CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

Anxiety; d Cycloserine; Depression; ERK; NMDA receptor

Indexed keywords

CYCLOSERINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; EMOTION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FORCED SWIMMING TEST; IMMOBILIZATION; MALE; MAZE TEST; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

AMYGDALA; ANALYSIS OF VARIANCE; ANIMALS; ANTIMETABOLITES; ANXIETY; CYCLOSERINE; EXCITATORY AMINO ACID AGONISTS; EXPLORATORY BEHAVIOR; INDIVIDUALITY; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; SIGNAL TRANSDUCTION; STATISTICS, NONPARAMETRIC;

EID: 38049017932     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2007.09.013     Document Type: Article

References (70)

1. Adams J.P., and Sweatt J.D. Molecular psychology: roles for the ERK MAP kinase cascade in memory. Annu Rev Pharmacol Toxicol 42 (2002) 135-163
2. Armario A., Gil M., Marti J., Pol O., and Balasch J. Influence of various acute stressors on the activity of adult male rats in a holeboard and in the forced swim test. Pharmacol Biochem Behav 39 (1991) 373-377
3. Bartanusz V., Aubry J.M., Pagliusi S., Jezova D., Baffi J., and Kiss J.Z. Stress-induced changes in messenger RNA levels of N-methyl-d-aspartate and AMPA receptor subunits in selected regions of the rat hippocampus and hypothalamus. Neuroscience 66 (1995) 247-252
4. Bignami G., De Acetis L., and Gatti G.L. Facilitation and impairment of avoidance responding by phenobarbital sodium, chlordiazepoxide and diazepam-the role of performance base lines. J Pharmacol Exp Ther 176 (1971) 725-732
5. Botreau F., and Gisquet-Verrier P. Memory reactivation, dissociated from behavioural expression, decreases ERK phosphorylation in the rat prefrontal cortex and amygdala. Behav Brain Res 169 (2006) 176-180
6. Chandler L.J., Sutton G., Dorairaj N.R., and Norwood D. N-methyl d-aspartate receptor-mediated bidirectional control of extracellular signal-regulated kinase activity in cortical neuronal cultures. J Biol Chem 276 (2001) 2627-2636
7. Chen Q., He S., Hu X.L., Yu J., Zhou Y., Zheng J., et al. Differential roles of NR2A- and NR2B-containing NMDA receptors in activity-dependent brain-derived neurotrophic factor gene regulation and limbic epileptogenesis. J Neurosci 27 (2007) 542-552
8. Crane G.E. Cycloserine as an antidepressant agent. Am J Psychiatry 115 (1959) 1025-1026
9. Crane G.E. The psychotropic effects of cycloserine: a new use for an antibiotic. Compr Psychiatry 2 (1961) 51-59
10. Davis M. Role of NMDA receptors and MAP kinase in the amygdala in extinction of fear: clinical implications for exposure therapy. Eur J Neurosci 16 (2002) 395-398
11. Desousa N.J., Wunderlich G.R., De Cabo C., and Vaccarino F.J. Individual differences in sucrose intake predict behavioral reactivity in rodent models of anxiety. Pharmacol Biochem Behav 60 (1998) 841-846
12. Dwivedi Y., Rizavi H.S., Roberts R.C., Conley R.C., Tamminga C.A., and Pandey G.N. Reduced activation and expression of ERK1/2 MAP kinase in the post-mortem brain of depressed suicide subjects. J Neurochem 77 (2001) 916-928
13. Engert F., and Bonhoeffer T. Dendritic spine changes associated with hippocampal long-term synaptic plasticity. Nature 399 (1999) 66-70
14. English J.D., and Sweatt J.D. A requirement for the mitogen-activated protein kinase cascade in hippocampal long term potentiation. J Biol Chem 272 (1997) 19103-19106
15. Feng P., Guan Z., Yang X., and Fang J. Impairments of ERK signal transduction in the brain in a rat model of depression induced by neonatal exposure of clomipramine. Brain Res 991 (2003) 195-205
16. Flood D.G., Finn J.P., Walton K.M., Dionne C.A., Contreras P.C., Miller M.S., et al. Immunolocalization of the mitogen-activated protein kinases p42MAPK and JNK1, and their regulatory kinases MEK1 and MEK4, in adult rat central nervous system. J Comp Neurol 398 (1998) 373-392
17. Goff D.C., and Coyle J.T. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am J Psychiatry 158 (2001) 1367-1377
18. Goff D.C., Henderson D.C., Evins A.E., and Amico E. A placebo-controlled crossover trial of d-cycloserine added to clozapine in patients with schizophrenia. Biol Psychiatry 45 (1999) 512-514
19. Goff D.C., Tsai G., Levitt J., Amico E., Manoach D., Schoenfeld D.A., et al. A placebo-controlled trial of d-cycloserine added to conventional neuroleptics in patients with schizophrenia. Arch Gen Psychiatry 56 (1999) 21-27
20. Goff D.C., Tsai G., Manoach D.S., and Coyle J.T. Dose-finding trial of d-cycloserine added to neuroleptics for negative symptoms in schizophrenia. Am J Psychiatry 152 (1995) 1213-1215
21. Goff D.C., Tsai G., Manoach D.S., Flood J., Darby D.G., and Coyle J.T. d-cycloserine added to clozapine for patients with schizophrenia. Am J Psychiatry 153 (1996) 1628-1630
22. Goldin M., and Segal M. Protein kinase C and ERK involvement in dendritic spine plasticity in cultured rodent hippocampal neurons. Eur J Neurosci 17 (2003) 2529-2539
23. Handley S.L., and McBlane J.W. An assessment of the elevated X-maze for studying anxiety and anxiety-modulating drugs. J Pharmacol Toxicol Methods 29 (1993) 129-138
24. Ho Y.J., Chen K.H., Tai M.Y., and Tsai Y.F. MK-801 suppresses muricidal behavior but not locomotion in olfactory bulbectomized rats: involvement of NMDA receptors. Pharmacol Biochem Behav 77 (2004) 641-646
25. Ho Y.J., Eichendorff J., and Schwarting R.K. Individual response profiles of male Wistar rats in animal models for anxiety and depression. Behav Brain Res 136 (2002) 1-12
26. Ho Y.J., Hsu L.S., Wang C.F., Hsu W.Y., Lai T.J., Hsu C.C., et al. Behavioral effects of d-cycloserine in rats: the role of anxiety level. Brain Res 1043 (2005) 179-185
27. Ho Y.J., Liu T., Tai M., Wen Z., Chow R.S., Tsai Y., et al. Effects of olfactory bulbectomy on NMDA receptor density in the rat brain. Brain Res 900 (2001) 214-218
28. Ho Y.J., Pawlak C.R., Guo L., and Schwarting R.K. Acute and long-term consequences of single MDMA administration in relation to individual anxiety levels in the rat. Behav Brain Res 149 (2004) 135-144
29. Ho Y.J., Wang C.F., Hsu W.Y., Tseng T., Hsu C.C., Kao M.D., et al. Psychoimmunological effects of dioscorea in ovariectomized rats: role of anxiety level. Ann Gen Psychiatry 6 (2007) 21
30. Hogg S. A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol Biochem Behav 54 (1996) 21-30
31. Howell D.C. Statistical methods for psychology (1992), Duxbury Press, Belmont p. 338
32. Huang T.Y., and Lin C.H. Role of amygdala MAPK activation on immobility behavior of forced swim rats. Behav Brain Res 173 (2006) 104-111
33. Impey S., Obrietan K., and Storm D.R. Making new connections: role of ERK/MAP kinase signaling in neuronal plasticity. Neuron 23 (1999) 11-14
34. Kishida K.T., Pao M., Holland S.M., and Klann E. NADPH oxidase is required for NMDA receptor-dependent activation of ERK in hippocampal area CA1. J Neurochem 94 (2005) 299-306
35. Komiyama N.H., Watabe A.M., Carlisle H.J., Porter K., Charlesworth P., Monti J., et al. SynGAP regulates ERK/MAPK signaling, synaptic plasticity, and learning in the complex with postsynaptic density 95 and NMDA receptor. J Neurosci 22 (2002) 9721-9732
36. Krugers H.J., Koolhaas J.M., Bohus B., and Korf J. A single social stress-experience alters glutamate receptor-binding in rat hippocampal CA3 area. Neurosci Lett 154 (1993) 73-77
37. Kuribara H., and Tadokoro S. Effects of psychotropic drugs on avoidance response in rats: role of baseline performances. Pharmacol Biochem Behav 11 (1979) 203-209
38. Kurino M., Fukunaga K., Ushio Y., and Miyamoto E. Activation of mitogen-activated protein kinase in cultured rat hippocampal neurons by stimulation of glutamate receptors. J Neurochem 65 (1995) 1282-1289
39. Land C., and Riccio D.C. d-Cycloserine: effects on long-term retention of a conditioned response and on memory for contextual attributes. Neurobiol Learn Mem 72 (1999) 158-168
40. Lawlor B.A., and Davis K.L. Does modulation of glutamatergic function represent a viable therapeutic strategy in Alzheimer's disease?. Biol Psychiatry 31 (1992) 337-350
41. Ledgerwood L., Richardson R., and Cranney J. Effects of d-cycloserine on extinction of conditioned freezing. Behav Neurosci 117 (2003) 341-349
42. Ledgerwood L., Richardson R., and Cranney J. d-cycloserine and the facilitation of extinction of conditioned fear: consequences for reinstatement. Behav Neurosci 118 (2004) 505-513
43. Loscher W., Wlaz P., Rundfeldt C., Baran H., and Honack D. Anticonvulsant effects of the glycine/NMDA receptor ligands d-cycloserine and d-serine but not R-(+)-HA-966 in amygdala-kindled rats. Br J Pharmacol 112 (1994) 97-106
44. Mandell G.L., and Petri W.A.J. Drugs used in the chemotherapy of tuberculosis, Mycobacterium avium complex disease, and leprosy. In: Godmann L.S., and Gillmann A. (Eds). The pharmacological basis of therapeutics (1996), McGraw-Hill, New York 1164-1165
45. Manji H.K., Drevets W.C., and Charney D.S. The cellular neurobiology of depression. Nat Med 7 (2001) 541-547
46. Olney J.W. New mechanisms of excitatory transmitter neurotoxicity. J Neural Transm Suppl 43 (1994) 47-51
47. Pawlak C.R., Ho Y.J., Schwarting R.K., and Bauhofer A. Relationship between striatal levels of interleukin-2 mRNA and plus-maze behaviour in the rat. Neurosci Lett 341 (2003) 205-208
48. Pawlak C.R., Schwarting R.K., and Bauhofer A. Cytokine mRNA levels in brain and peripheral tissues of the rat: relationships with plus-maze behavior. Brain Res Mol Brain Res 137 (2005) 159-165
49. Pellow S., Chopin P., File S.E., and Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14 (1985) 149-167
50. Pinel J.P. Biopsychology. 5th ed. (2002), Allyn and Bacon, New York, USA p. 471
51. Porsolt R.D., Le Pichon M., and Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 266 (1977) 730-732
52. Qi X., Lin W., Li J., Pan Y., and Wang W. The depressive-like behaviors are correlated with decreased phosphorylation of mitogen-activated protein kinases in rat brain following chronic forced swim stress. Behav Brain Res 175 (2006) 233-240
53. Ressler K.J., Rothbaum B.O., Tannenbaum L., Anderson P., Graap K., Zimand E., et al. Cognitive enhancers as adjuncts to psychotherapy: use of d-cycloserine in phobic individuals to facilitate extinction of fear. Arch Gen Psychiatry 61 (2004) 1136-1144
54. Rodgers R.J., and Cole J.C. The elevated plus-maze: pharmacology, methodology and ethology. In: Cooper S.J., and Hendrie C.A. (Eds). Ethology and psychopharmacology (1995), Wiley, London 9-44
55. Ruiz R.C. d-Cycloserine in the treatment of pulmonary tuberculosis resistant to the standard drugs: a study of 116 cases. Dis Chest 45 (1964) 181-186
56. Schafe G.E., Atkins C.M., Swank M.W., Bauer E.P., Sweatt J.D., and LeDoux J.E. Activation of ERK/MAP kinase in the amygdala is required for memory consolidation of pavlovian fear conditioning. J Neurosci 20 (2000) 8177-8187
57. Schwarting R.K., Thiel C.M., Muller C.P., and Huston J.P. Relationship between anxiety and serotonin in the ventral striatum. Neuroreport 9 (1998) 1025-1029
58. Selcher J.C., Atkins C.M., Trzaskos J.M., Paylor R., and Sweatt J.D. A necessity for MAP kinase activation in mammalian spatial learning. Learn Mem 6 (1999) 478-490
59. Shirayama Y., Chen A.C., Nakagawa S., Russell D.S., and Duman R.S. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 22 (2002) 3251-3261
60. Sweatt J.D. The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory. J Neurochem 76 (2001) 1-10
61. Taghzouti K., Lamarque S., Kharouby M., and Simon H. Interindividual differences in active and passive behaviors in the forced-swimming test: implications for animal models of psychopathology. Biol Psychiatry 45 (1999) 750-758
62. Takaori S., Yada N., and Mori G. Effects of psychotropic agents on Sidman avoidance response in good- and poor-performing rats. Jpn J Pharmacol 19 (1969) 587-596
63. Thiel C.M., Huston J.P., and Schwarting R.K. Cholinergic activation in frontal cortex and nucleus accumbens related to basic behavioral manipulations: handling, and the role of post-handling experience. Brain Res 812 (1998) 121-132
64. Thiel C.M., Muller C.P., Huston J.P., and Schwarting R.K. High versus low reactivity to a novel environment: behavioural, pharmacological and neurochemical assessments. Neuroscience 93 (1999) 243-251
65. van Berckel B.N., Hijman R., van der Linden J.A., Westenberg H.G., van Ree J.M., and Kahn R.S. Efficacy and tolerance of d-cycloserine in drug-free schizophrenic patients. Biol Psychiatry 40 (1996) 1298-1300
66. van Berckel B.N., Lipsch C., Timp S., Gispen-de Wied C., Wynne H., van Ree J.M., et al. Behavioral and neuroendocrine effects of the partial NMDA agonist d-cycloserine in healthy subjects. Neuropsychopharmacology 16 (1997) 317-324
67. Walker D.L., Ressler K.J., Lu K.T., and Davis M. Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of d-cycloserine as assessed with fear-potentiated startle in rats. J Neurosci 22 (2002) 2343-2351
68. Wilcox R.R. New designs in analysis of variance. Annu Rev Psychol 38 (1987) 29-60
69. 2+-independent signaling pathway to extracellular signal-regulated protein kinase by coactivation of NMDA receptors and metabotropic glutamate receptor 5 in neurons. J Neurosci 24 (2004) 10846-10857
70. Yang Y.L., and Lu K.T. Facilitation of conditioned fear extinction by d-cycloserine is mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase cascades and requires de novo protein synthesis in basolateral nucleus of amygdala. Neuroscience 134 (2005) 247-260